Capital Health Partners Announces Rebrand of Calea Pharmacies to Royal Drugs

Capital Health Partners is pleased to announce the rebranding of its Calea pharmacy locations to Royal Drugs, effective November 14, 2025. This transition marks a significant milestone in the company’s ongoing commitment to delivering premium pharmacy services across Canada.

The rebrand affects four pharmacy locations currently operating under the Calea name in Mississauga, ON; Hamilton, ON; Calgary, AB; and Burnaby, BC. These locations will continue to provide the same high-quality services and support, now unified under the trusted Royal Drugs brand.

This change follows Capital Health Partners’ August 2025 acquisition of Calea (Canada). As the parent company of Ontario Medical Supply and Royal Drugs, Capital Health Partners is aligning its pharmacy operations under a single, recognizable brand to enhance service consistency and client experience.

“The Royal Drugs name reflects our dedication to excellence in pharmacy care,” said Yves Portelance, CEO at Capital Health Partners. “It represents the premium quality of our products and services, and the exceptional care our clients deserve. While the name is changing, our commitment to our clients remains the same.”

Clients and partners can expect no disruption to services during the transition. All existing operations, staff, and service offerings will remain unchanged.